After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of IGM Biosciences Inc is $81.16M. A total of 0.75 million shares were traded on the day, compared to an average of 468.19K shares.
In the most recent transaction, Weber Steven sold 486 shares of IGMS for 1.20 per share on Jun 16 ’25. After the transaction, the PRINCIPAL ACCOUNTING OFFICER now owns 26,530 company shares. In a previous transaction on Jun 16 ’25, Tahir Misbah sold 1,522 shares at 1.20 per share. IGMS shares that CHIEF FINANCIAL OFFICER owns now total 178,802.
Among the insiders who sold shares, Harler Mary Beth disposed of 1,522 shares on Jun 16 ’25 at a per-share price of $1.20. This resulted in the Chief Executive Officer holding 338,181 shares of IGMS after the transaction. In another insider transaction, Decker Lisa Lynn sold 951 shares at $1.20 per share on Jun 16 ’25. Company shares held by the CHIEF BUSINESS OFFICER now total 72,578.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IGMS has a high of $22.50 and a low of $0.92.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IGMS’s latest balance sheet shows that the firm has $229.54M in Cash & Short Term Investments as of fiscal 2021. There were $28.76M in debt and $27.78M in liabilities at the time. Its Book Value Per Share was $0.01, while its Total Shareholder’s Equity was $244.91M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IGMS is Buy with a score of 2.86.
